129 related articles for article (PubMed ID: 14557015)
41. HPV infection in cervical-cancer cases in Russia.
Samoylova EV; Shaikhaiev GO; Petrov SV; Kisseljova NP; Kisseljov FL
Int J Cancer; 1995 May; 61(3):337-41. PubMed ID: 7729945
[TBL] [Abstract][Full Text] [Related]
42. [Retrospective analysis of relationship between progression and regression of dysplasia and existence of HPV DNA by in situ hybridization].
Ebisawa K; Shinozuka T; Kawai K; Fujii A; Kuroshima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1994 Oct; 46(10):1041-8. PubMed ID: 7814934
[TBL] [Abstract][Full Text] [Related]
43. Pathogenetic significance of p53 and c-Ki-ras gene mutations and human papillomavirus DNA integration in adenocarcinoma of the uterine cervix and uterine isthmus.
Jiko K; Tsuda H; Sato S; Hirohashi S
Int J Cancer; 1994 Dec; 59(5):601-6. PubMed ID: 7960232
[TBL] [Abstract][Full Text] [Related]
44. Cervical squamous dysplasias and carcinomas with immunodetectable p53 frequently contain HPV.
Mittal KR; Lin O; Chan W; Goswami S; Demopoulos RI
Gynecol Oncol; 1995 Sep; 58(3):289-94. PubMed ID: 7672694
[TBL] [Abstract][Full Text] [Related]
45. FOXA1 in HPV associated carcinomas: Its expression in carcinomas of the head and neck and of the uterine cervix.
Karpathiou G; Da Cruz V; Casteillo F; Mobarki M; Dumollard JM; Chauleur C; Forest F; Prades JM; Peoc'h M
Exp Mol Pathol; 2017 Apr; 102(2):230-236. PubMed ID: 28209524
[TBL] [Abstract][Full Text] [Related]
46. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva.
Milde-Langosch K; Albrecht K; Joram S; Schlechte H; Giessing M; Löning T
Int J Cancer; 1995 Nov; 63(5):639-45. PubMed ID: 7591279
[TBL] [Abstract][Full Text] [Related]
47. Detection of human papillomavirus in organs of upper genital tract in women with cervical cancer.
Giordano G; D'Adda T; Gnetti L; Froio E; Merisio C; Melpignano M
Int J Gynecol Cancer; 2006; 16(4):1601-7. PubMed ID: 16884373
[TBL] [Abstract][Full Text] [Related]
48. Basal keratinocyte tetrasomy in low-grade squamous intra-epithelial lesions of the cervix is restricted to high and intermediate risk HPV infection but is not type-specific.
Giannoudis A; Evans MF; Southern SA; Herrington CS
Br J Cancer; 2000 Jan; 82(2):424-8. PubMed ID: 10646899
[TBL] [Abstract][Full Text] [Related]
49. Relationships between c-Ki-ras mutations, HPV types, and prognostic indicators in invasive endocervical adenocarcinomas.
Koulos JP; Wright TC; Mitchell MF; Silva E; Atkinson EN; Richart RM
Gynecol Oncol; 1993 Mar; 48(3):364-9. PubMed ID: 8385060
[TBL] [Abstract][Full Text] [Related]
50. Analysis of ras point mutations and human papillomavirus 16 and 18 in cervical carcinomata and their metastases.
Willis G; Jennings B; Ball RY; New NE; Gibson I
Gynecol Oncol; 1993 Jun; 49(3):359-64. PubMed ID: 8390962
[TBL] [Abstract][Full Text] [Related]
51. [Analysis of prevalence of point mutations in codon 12 of oncogene K-ras from non-cancerous samples of cervical cytology positive for type 16 or 18 PVH].
Golijow CD; Mourón SA; Gómez MA; Dulout FN
Invest Clin; 1999 Dec; 40(4):257-66. PubMed ID: 10666952
[TBL] [Abstract][Full Text] [Related]
52. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
[TBL] [Abstract][Full Text] [Related]
53. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas.
Ikenberg H; Matthay K; Schmitt B; Bauknecht T; Kiechle-Schwarz M; Göppinger A; Pfleiderer A
Cancer; 1995 Jul; 76(1):57-66. PubMed ID: 8630877
[TBL] [Abstract][Full Text] [Related]
54. Identification of H, K, and N-ras point mutations in stage IB cervical carcinoma.
Grendys EC; Barnes WA; Weitzel J; Sparkowski J; Schlegel R
Gynecol Oncol; 1997 May; 65(2):343-7. PubMed ID: 9159349
[TBL] [Abstract][Full Text] [Related]
55. Lack of synergistic association between human papillomavirus and ras gene point mutation in laryngeal carcinomas.
Shidara K; Suzuki T; Hara F; Nakajima T
Laryngoscope; 1994 Aug; 104(8 Pt 1):1008-12. PubMed ID: 8052064
[TBL] [Abstract][Full Text] [Related]
56. Mutations of p53 and human papillomavirus infection in cervical carcinoma.
Paquette RL; Lee YY; Wilczynski SP; Karmakar A; Kizaki M; Miller CW; Koeffler HP
Cancer; 1993 Aug; 72(4):1272-80. PubMed ID: 8393371
[TBL] [Abstract][Full Text] [Related]
57. H-ras codon 12 mutation in cervical dysplasia.
Van Le L; Stoerker J; Rinehart CA; Fowler WC
Gynecol Oncol; 1993 May; 49(2):181-4. PubMed ID: 8389312
[TBL] [Abstract][Full Text] [Related]
58. [Identification of encoding and regulatory sequences of RAR-alpha receptor in intraepithelial neoplasia and in invasive cervical carcinomas associated with HPV types 16 and 18].
Kwaśniewska A; Zimna K; Sominka J; Goździcka-Józefiak A; Semczuk M
Ginekol Pol; 2002 Mar; 73(3):167-70. PubMed ID: 12092248
[TBL] [Abstract][Full Text] [Related]
59. [hTERC gene amplification and expression of human papillomavirus in cervical carcinogenesis].
Li SH; Liu LL; Ma HX; Wang QH; Bai W
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):121-2. PubMed ID: 22455890
[No Abstract] [Full Text] [Related]
60. Well-differentiated villoglandular adenocarcinoma of the uterine cervix: oncogene/tumor suppressor gene alterations and human papillomavirus genotyping.
Jones MW; Kounelis S; Papadaki H; Bakker A; Swalsky PA; Woods J; Finkelstein SD
Int J Gynecol Pathol; 2000 Apr; 19(2):110-7. PubMed ID: 10782406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
